Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IDT Biologika Appoints Chief Commercial Officer | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

IDT Biologika Appoints Chief Commercial Officer

Frederico Pollano boasts extensive experience in management positions at global CDMOs in the pharmaceutical and biotechnology industry.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Federico Pollano.

IDT Biologika, a global contract development and manufacturing organization (CDMO), has appointed Federico Pollano as Chief Commercial Officer, effective March 1, 2025.

“In Federico Pollano, we have found an outstanding personality for this position, both personally and professionally. We want to strengthen our global network and strategically expand our business, and Federico Pollano’s many years of experience in the CDMO business will provide us with important inspiration,” remarks Dr. Sally Choe, Co-CEO IDT Biologika.

Experience

Federico Pollano has extensive experience in management positions at global CDMOs in the pharmaceutical and biotechnology industry.

Prior to joining IDT Biologika he was Senior Vice President Business Development at Rentschler Biopharma for the past seven years. During this period, he assumed responsibility for sales management and customer service. He also joined the Extended Executive Board in 2023. Before taking on this role, Pollano built up the CDMO business as Global Director Contract Manufacturing and Business Development at Polpharma Biologics and was Managing Director at Richter-Helm-BioTec and Executive Manager Pharmaceuticals at Helm Pharmaceuticals. He also previously held important stations at GSK and Ratiopharm.

“I am very much looking forward to my new role at IDT Biologika and especially to contributing my skills and dedication to this great team,” Pollano remarks. “IDT has already established itself as a reliable partner in the market and is currently experiencing growth alongside SK bioscience. I am excited about contributing to this growth, particularly by strengthening and expanding relationships with customers and leveraging the full range of IDT’s capabilities to ensure the success of our clients’ projects.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics